Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Circulatory endostatin level and risk of cardiovascular events in patients with end-stage renal disease on hemodialysis: Jin Sug Kim, Miji Kim, Kyung Hwan Jeong et al.; Kidney Res Clin Pract. 2024;43(2):226-235. Published online March 13, 2024; DOI: https://doi.org/10.23876/j.krcp.22.227; Full text PubReader ePub PDF

Fasting blood glucose and the risk of all-cause mortality in patients with diabetes mellitus undergoing hemodialysis: Soo-Young Yoon, Jin Sug Kim, Gang Jee Ko et al.; Received January 15, 2023 Accepted January 15, 2023 Published online January 26, 2024; [Epub ahead of print]; Full text PubReader ePub PDF

Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease: Yoon Kyung Choi, Ji Hyun Yang, Shin Young Ahn et al.; Kidney Res Clin Pract. 2019;38(1):42-48. Published online February 12, 2019; DOI: https://doi.org/10.23876/j.krcp.18.0052
Web of Science 9 Cited By 6; Full text PubReader PDF

Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients: Mi Yeon Jung, Soon Young Hwang, Yu Ah Hong et al.; Kidney Res Clin Pract. 2015;34(1):20-27. Published online January 15, 2015; DOI: https://doi.org/10.1016/j.krcp.2014.11.003
Web of Science 9 Cited By 9; Full text PubReader PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,646	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,565	C4d Puzzle in ABO-incompatible kidney transplantation
7,992	How should we treat acute kidney injury caused by renal congestion?
12,805	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,874	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.